BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2480068)

  • 1. Peritoneovenous shunts palliate malignant ascites.
    Edney JA; Hill A; Armstrong D
    Am J Surg; 1989 Dec; 158(6):598-601. PubMed ID: 2480068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Denver peritoneovenous shunts for the management of malignant ascites: a review of the literature in the post LeVeen Era.
    White MA; Agle SC; Padia RK; Zervos EE
    Am Surg; 2011 Aug; 77(8):1070-5. PubMed ID: 21944526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Denver type for peritoneovenous shunting of malignant ascites.
    Roussel JG; Kroon BB; Hart GA
    Surg Gynecol Obstet; 1986 Mar; 162(3):235-40. PubMed ID: 2420017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombocytopenia and laboratory evidence of disseminated intravascular coagulation after shunts for ascites in malignant disease.
    Tempero MA; Davis RB; Reed E; Edney J
    Cancer; 1985 Jun; 55(11):2718-21. PubMed ID: 3995480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal pulmonary tumor embolization following peritoneovenous shunting for malignant ascites.
    Smith RR; Sternberg SS; Paglia MA; Golbey RB
    J Surg Oncol; 1981; 16(1):27-35. PubMed ID: 6257978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneovenous shunts for palliation of the patient with malignant ascites.
    Schumacher DL; Saclarides TJ; Staren ED
    Ann Surg Oncol; 1994 Sep; 1(5):378-81. PubMed ID: 7531600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiological insertion of Denver peritoneovenous shunts for malignant refractory ascites: a retrospective multicenter study (JIVROSG-0809).
    Sugawara S; Sone M; Arai Y; Sakamoto N; Aramaki T; Sato Y; Inaba Y; Takeuchi Y; Ueno T; Matsueda K; Moriguchi M; Tsushima T
    Cardiovasc Intervent Radiol; 2011 Oct; 34(5):980-8. PubMed ID: 21191592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant ascites. A comparison of peritoneovenous shunting and nonoperative management.
    Gough IR; Balderson GA
    Cancer; 1993 Apr; 71(7):2377-82. PubMed ID: 7680947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneovenous shunting for nongynecologic malignant ascites.
    Bieligk SC; Calvo BF; Coit DG
    Cancer; 2001 Apr; 91(7):1247-55. PubMed ID: 11283923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneovenous shunting for cirrhotic versus malignant ascites.
    Kostroff KM; Ross DW; Davis JM
    Surg Gynecol Obstet; 1985 Sep; 161(3):204-8. PubMed ID: 2412302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of refractory chylous ascites with peritoneovenous shunts.
    Huang Y; Gloviczki P; Duncan AA; Fleming MD; Driscoll DJ; Kalra M; Oderich GS; Bower TC
    J Vasc Surg Venous Lymphat Disord; 2017 Jul; 5(4):538-546. PubMed ID: 28623993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of Denver peritoneovenous shunting.
    Lund RH; Moritz MW
    Arch Surg; 1982 Jul; 117(7):924-8. PubMed ID: 6979992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications of peritoneovenous shunt for malignant ascites.
    Lokich J; Reinhold R; Silverman M; Tullis J
    Cancer Treat Rep; 1980; 64(2-3):305-9. PubMed ID: 6157465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneovenous shunts for malignant ascites.
    Sonnenfeld T; Tydén G
    Acta Chir Scand; 1986 Feb; 152():117-21. PubMed ID: 3953206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneovenous shunts in patients with intractable ascites: palliation at what price?
    Zervos EE; McCormick J; Goode SE; Rosemurgy AS
    Am Surg; 1997 Feb; 63(2):157-62. PubMed ID: 9012430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved quality of life for malignant ascites patients by Denver peritoneovenous shunts.
    Tomiyama K; Takahashi M; Fujii T; Kunisue H; Kanaya Y; Maruyama S; Yokoyama N; Nakao A; Soda M; Shimizu N
    Anticancer Res; 2006; 26(3B):2393-5. PubMed ID: 16821622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-infective complications of peritoneovenous anastomosis (LeVeen shunt)].
    Castells LL; Comas P; Lucea D; Charco R; González A; Vargas V
    Rev Esp Enferm Dig; 1992 Nov; 82(5):368-9. PubMed ID: 1485993
    [No Abstract]   [Full Text] [Related]  

  • 18. Peritoneovenous shunting for intractable ascites.
    Tyden G; Samnegård H; Thulin L
    Acta Chir Scand; 1982; 148(7):597-600. PubMed ID: 7168289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneovenous shunting for ascites in cancer patients.
    Oosterlee J
    Br J Surg; 1980 Sep; 67(9):663-6. PubMed ID: 6159041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Application of Percutaneous Peritoneovenous (Denver) Shunt in Treating Chylous Ascites in Cancer Patients.
    Yarmohammadi H; Brody LA; Erinjeri JP; Covey AM; Boas FE; Ziv E; Maybody M; Gonzalez-Aguirre AJ; Brown KT; Sheinfeld J; Getrajdman GI
    J Vasc Interv Radiol; 2016 May; 27(5):665-73. PubMed ID: 26965362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.